Canada · Biotechnology startup
Canada · Abdera Therapeutics
Abdera is an oncology company developing targeted alpha therapies (TATs) for patients with relapsed, refractory, and metastatic cancers.
Funding reportedLast round: Series B
What company datasets say Abdera Therapeutics raised
Funding, as reported
Reported in all148.3Min the source's currency
Rounds3
Last roundSeries B
Last round dateApr 2023
Investors listed7
Biotechnology in Canada
Startups like it
- The Green Organic Dutchman HoldingsAncaster · founded 2012
HLS TherapeuticsCaledon · founded 2014- Chinook TherapeuticsVancouver · founded 2019
Acerta EnergyCalgary · founded 2013- Enobia PharmaMontreal · founded 1997
Kintara TherapeuticsVancouver · founded 2010
Cannara BiotechSaint Laurent · founded 2018
Reunion NeuroscienceToronto · founded 2019
Is this your company?
Add your raise, your deck and your story, and put Abdera Therapeutics in front of investors. Or tell us what we have wrong.